Latigo J - Search Results

1

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965.

Braga M, Kaliszczak M, Carroll L, Schug ZT, Heinzmann K, Baxan N, Benito A, Valbuena GN, Stribbling S, Beckley A, Mackay G, Mauri F, Latigo J, Barnes C, Keun H, Gottlieb E, Aboagye EO. Braga M, et al. Among authors: latigo j. Cancers (Basel). 2020 Jun 26;12(6):1703. doi: 10.3390/cancers12061703. Cancers (Basel). 2020. PMID: 32604836 Free PMC article.

2

Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo.

Leyton J, Latigo JR, Perumal M, Dhaliwal H, He Q, Aboagye EO. Leyton J, et al. Among authors: latigo jr. Cancer Res. 2005 May 15;65(10):4202-10. doi: 10.1158/0008-5472.CAN-04-4008. Cancer Res. 2005. PMID: 15899811

3

Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography.

Perumal M, Pillai RG, Barthel H, Leyton J, Latigo JR, Forster M, Mitchell F, Jackman AL, Aboagye EO. Perumal M, et al. Among authors: latigo jr. Cancer Res. 2006 Sep 1;66(17):8558-64. doi: 10.1158/0008-5472.CAN-06-0898. Cancer Res. 2006. PMID: 16951168

4

The uptake of 3'-deoxy-3'-[18F]fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels.

Barthel H, Perumal M, Latigo J, He Q, Brady F, Luthra SK, Price PM, Aboagye EO. Barthel H, et al. Among authors: latigo j. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):257-63. doi: 10.1007/s00259-004-1611-0. Epub 2004 Sep 4. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791434

5

The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

Pardo OE, Latigo J, Jeffery RE, Nye E, Poulsom R, Spencer-Dene B, Lemoine NR, Stamp GW, Aboagye EO, Seckl MJ. Pardo OE, et al. Among authors: latigo j. Cancer Res. 2009 Nov 15;69(22):8645-51. doi: 10.1158/0008-5472.CAN-09-1576. Epub 2009 Nov 10. Cancer Res. 2009. PMID: 19903855

6

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

Leyton J, Alao JP, Da Costa M, Stavropoulou AV, Latigo JR, Perumal M, Pillai R, He Q, Atadja P, Lam EW, Workman P, Vigushin DM, Aboagye EO. Leyton J, et al. Among authors: latigo jr. Cancer Res. 2006 Aug 1;66(15):7621-9. doi: 10.1158/0008-5472.CAN-05-3962. Cancer Res. 2006. PMID: 16885362

7

Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.

Sanderson L, Taylor GW, Aboagye EO, Alao JP, Latigo JR, Coombes RC, Vigushin DM. Sanderson L, et al. Among authors: latigo jr. Drug Metab Dispos. 2004 Oct;32(10):1132-8. doi: 10.1124/dmd.104.000638. Epub 2004 Jul 21. Drug Metab Dispos. 2004. PMID: 15269190

8

Adaptation to HIF-1 deficiency by upregulation of the AMP/ATP ratio and phosphofructokinase activation in hepatomas.

Golinska M, Troy H, Chung YL, McSheehy PM, Mayr M, Yin X, Ly L, Williams KJ, Airley RE, Harris AL, Latigo J, Perumal M, Aboagye EO, Perrett D, Stubbs M, Griffiths JR. Golinska M, et al. Among authors: latigo j. BMC Cancer. 2011 May 25;11:198. doi: 10.1186/1471-2407-11-198. BMC Cancer. 2011. PMID: 21612605 Free PMC article.

9

Radiosynthesis of 4-[(2-chloroethyl)(2-[(11)C]ethyl)amino]-phenoxycarbonyl-l-glutamic acid a half mustard prodrug as a potential probe for imaging antibody- and gene-directed enzyme prodrug therapy with positron emission tomography.

Malik N, Luthra SK, Burke P, Price PM, Aboagye EO, Latigo J, Zhao Y, Brady F. Malik N, et al. Among authors: latigo j. Appl Radiat Isot. 2004 Jun;60(6):825-34. doi: 10.1016/j.apradiso.2004.01.001. Appl Radiat Isot. 2004. PMID: 15110346

10

HPMA copolymers platinates containing dicarboxylato ligands. Preparation, characterisation and in vitro and in vivo evaluation.

Gianasi E, Buckley RG, Latigo J, Wasil M, Duncan R. Gianasi E, et al. Among authors: latigo j. J Drug Target. 2002 Nov;10(7):549-56. doi: 10.1080/1061186021000072456. J Drug Target. 2002. PMID: 12683722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters